Infliximab for the Treatment of Adults With Psoriasis

Health Technology Assessment - United Kingdom
doi 10.3310/hta13suppl1/09
Full Text
Abstract

Available in full text

Date
Authors
Publisher

National Institute for Health Research

Related search

Treatment of Severe Psoriasis With Infliximab

Therapeutics and Clinical Risk Management
2008English

Infliximab for the Treatment of Plaque Psoriasis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Treatment of Psoriasis: Focus on Clinic-Based Management With Infliximab

American Journal of Clinical Dermatology
DermatologyMedicine
2014English

Risankizumab for the Treatment of Plaque Psoriasis in Adults

Prescriber
Pharmacology
2019English

Tildrakizumab for the Treatment of Plaque Psoriasis in Adults

Prescriber
Pharmacology
2019English

Dose-Creep of Infliximab During Psoriasis Treatment: An Observational Study

Acta Dermato-Venereologica
DermatologyMedicine
2012English

Successful Treatment of Juvenile Generalized Pustular Psoriasis With Infliximab Therapy: Two Case Reports

Journal of International Medical Research
BiochemistryMedicineCell Biology
2020English

211 Adults With Psoriasis Receive More Opioid Prescriptions Than Adults Without Psoriasis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Immunosuppressants for the Treatment of Psoriasis

Journal of Nihon University Medical Association
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy